JP2020500205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500205A5 JP2020500205A5 JP2019528114A JP2019528114A JP2020500205A5 JP 2020500205 A5 JP2020500205 A5 JP 2020500205A5 JP 2019528114 A JP2019528114 A JP 2019528114A JP 2019528114 A JP2019528114 A JP 2019528114A JP 2020500205 A5 JP2020500205 A5 JP 2020500205A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- dione
- isoindoline
- dioxapiperidin
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611041317 | 2016-11-24 | ||
| CN201611041317.5 | 2016-11-24 | ||
| PCT/CN2017/112668 WO2018095377A1 (zh) | 2016-11-24 | 2017-11-23 | 哌啶-2,6-二酮衍生物以及溃疡性结肠炎的治疗 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020500205A JP2020500205A (ja) | 2020-01-09 |
| JP2020500205A5 true JP2020500205A5 (enExample) | 2020-08-20 |
| JP7143296B2 JP7143296B2 (ja) | 2022-09-28 |
Family
ID=62194806
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528114A Active JP7143296B2 (ja) | 2016-11-24 | 2017-11-23 | ピペリジン－２，６－ジオン誘導体及び潰瘍性結腸炎の治療 |
| JP2019528110A Active JP7143295B2 (ja) | 2016-11-24 | 2017-11-23 | ピペリジン－２，６－ジオン誘導体及びクローン病の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528110A Active JP7143295B2 (ja) | 2016-11-24 | 2017-11-23 | ピペリジン－２，６－ジオン誘導体及びクローン病の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20220372013A2 (enExample) |
| EP (2) | EP3546450A4 (enExample) |
| JP (2) | JP7143296B2 (enExample) |
| CN (2) | CN108101886A (enExample) |
| AU (2) | AU2017366514B2 (enExample) |
| CA (2) | CA3049161C (enExample) |
| WO (2) | WO2018095378A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220372013A2 (en) | 2016-11-24 | 2022-11-24 | Tianjin Hemay Pharmaceutical Sci-Tech Co., Ltd | Piperidine-2,6-dione derivatives and crohn's disease treating |
| CN108727319A (zh) * | 2018-09-05 | 2018-11-02 | 常州大学 | 一种3-硝基邻苯二甲酸酐的制备方法 |
| CN109293631B (zh) * | 2018-11-30 | 2020-05-08 | 常州制药厂有限公司 | 3-氨基-n-(2，6-二氧代-3-哌啶基)-邻苯二甲酰亚胺化合物的制备方法 |
| GB202002926D0 (en) * | 2020-02-28 | 2020-04-15 | Benevolentai Tech Limited | Compositions and uses thereof |
| CN111320604B (zh) * | 2020-04-22 | 2021-02-09 | 牡丹江医学院 | 一种治疗小儿口腔黏膜疾病的化合物、制备方法及其用途 |
| CN118370746A (zh) * | 2024-04-25 | 2024-07-23 | 江苏省中医院 | 马尿酸在制备溃疡性结肠炎治疗药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2172474B1 (es) | 2001-03-01 | 2004-01-16 | Fundacion Universitaria San Pa | Derivados de glutarimida como agentes terapeuticos. |
| EP1336602A1 (en) * | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| CN100488959C (zh) * | 2003-03-27 | 2009-05-20 | 天津和美生物技术有限公司 | 水溶性的酞胺哌啶酮衍生物 |
| WO2005028436A2 (en) * | 2003-09-17 | 2005-03-31 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Thalidomide analogs as tnf-alpha modulators |
| CN101141960A (zh) * | 2005-01-25 | 2008-03-12 | 细胞基因公司 | 使用4-氨基-2-(3-甲基-2,6-二氧代哌啶-3-基)-异吲哚-1,3-二酮的方法和组合物 |
| CN100383139C (zh) | 2005-04-07 | 2008-04-23 | 天津和美生物技术有限公司 | 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物 |
| CN1961876A (zh) * | 2005-11-08 | 2007-05-16 | 北京恩华医药研究院 | 邻苯二甲酰亚胺衍生物在制备抗新血管生成的药物中的用途 |
| US9193989B2 (en) | 2010-06-18 | 2015-11-24 | Taiho Pharmaceutical Co., Ltd. | PRPK-TPRKB modulators and uses thereof |
| EP2981262A1 (en) | 2013-04-02 | 2016-02-10 | Celgene Corporation | Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers |
| US20220372013A2 (en) | 2016-11-24 | 2022-11-24 | Tianjin Hemay Pharmaceutical Sci-Tech Co., Ltd | Piperidine-2,6-dione derivatives and crohn's disease treating |
-
2017
- 2017-11-23 US US16/464,228 patent/US20220372013A2/en active Pending
- 2017-11-23 AU AU2017366514A patent/AU2017366514B2/en active Active
- 2017-11-23 WO PCT/CN2017/112669 patent/WO2018095378A1/zh not_active Ceased
- 2017-11-23 CA CA3049161A patent/CA3049161C/en active Active
- 2017-11-23 JP JP2019528114A patent/JP7143296B2/ja active Active
- 2017-11-23 WO PCT/CN2017/112668 patent/WO2018095377A1/zh not_active Ceased
- 2017-11-23 AU AU2017366515A patent/AU2017366515B2/en active Active
- 2017-11-23 JP JP2019528110A patent/JP7143295B2/ja active Active
- 2017-11-23 US US16/464,224 patent/US11485724B2/en active Active
- 2017-11-23 EP EP17874499.1A patent/EP3546450A4/en active Pending
- 2017-11-23 EP EP17873820.9A patent/EP3546449A4/en active Pending
- 2017-11-23 CN CN201711184758.5A patent/CN108101886A/zh active Pending
- 2017-11-23 CN CN201711185728.6A patent/CN108101887A/zh active Pending
- 2017-11-23 CA CA3045703A patent/CA3045703C/en active Active
-
2022
- 2022-06-03 US US17/832,518 patent/US11873287B2/en active Active
-
2023
- 2023-12-08 US US18/533,755 patent/US12331030B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500205A5 (enExample) | ||
| JP2020500204A5 (enExample) | ||
| WO1992009279A1 (fr) | Derive de 2-arylthiazole et composition pharmaceutique contenant ce derive | |
| TW200815358A (en) | Organic compounds | |
| EA011087B1 (ru) | Соединения и фармацевтические композиции для лечения воспалительных заболеваний | |
| JP2012501346A5 (enExample) | ||
| FR2943669A1 (fr) | Derives de nicotinamide,leur preparation et leur application en therapeutique | |
| JP7161466B2 (ja) | グリコピロニウム化合物を作製するための方法及び使用する方法 | |
| JP2007261945A (ja) | チアゾール誘導体 | |
| JP2014031374A (ja) | キノリン類化合物及びその薬物組成物、製造方法並びに応用 | |
| JP7422741B2 (ja) | ２－［（３ｒ）－３－メチルモルホリン－４－イル］－４－（１－メチル－１ｈ－ピラゾール－５－イル）－８－（１ｈ－ピラゾール－５－イル）－１，７－ナフチリジンを調製する方法 | |
| JP6174161B2 (ja) | ２−アミノニコチン酸ベンジルエステル誘導体の製造方法 | |
| WO1996013497A1 (en) | Tetrahydroisoquinoline derivative and medicinal preparation containing the same | |
| JPH0128746B2 (enExample) | ||
| WO2003030905A1 (en) | Dihydroorotate dehydrogenase inhibitor | |
| JP2021525784A (ja) | チエノ［２，３−ｃ］ピリダジン−４（１Ｈ）−オン系誘導体及びその使用 | |
| JPH08188546A (ja) | カルコン誘導体 | |
| JPS5838277A (ja) | スピロチアゾリジニルピペラジン誘導体 | |
| JP6961595B2 (ja) | ４−アルコキシ−３−トリフルオロメチルベンジルアルコールの製造方法 | |
| JP3058399B2 (ja) | ［［４−置換アセチル−ｏ−フェニレン］ジオキシ］ジ酢酸誘導体及びその製造方法 | |
| JPH10273464A (ja) | 置換カテコール誘導体 | |
| EP0713865A1 (fr) | Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse | |
| JP7128629B2 (ja) | ルビプロストンの製造方法 | |
| JP2004315535A (ja) | ヘキサヒドロピリダジン−３−カルボン酸誘導体の調製方法 | |
| JP3272340B2 (ja) | １−［（シクロペント−３−エン−１−イル）メチル］−５−エチル−６−（３，５−ジメチルベンゾイル）−２，４−ピリミジンジオンの製造方法 |